Peter Sandys

7 results

Seroba managing partner Peter Sandys

Irish venture capital firm Seroba Life Sciences stands to make a return of up to €100 million following the recent sale of a company it invested in ju(...)

Brian Caulfield. Photograph: David Sleator

European venture capital activity is still relatively small compared with Silicon Valley and Asia, but the situation is rapidly changing. While things(...)

The new chairman of the Irish Venture Capital Association, Peter Sandys: he replaces Michael Murphy, a partner with Investec Ventures Ireland, whose tenure as chairman has come to an end. Photograph: Karl Hussey/Fennells

Peter Sandys of Seroba Life Sciences has been elected chairman of the Irish Venture Capital Association (IVCA), the industry body that represents VC f(...)

The fund launched by Seroba Life Sciences will typically place up to €10 million with each business it chooses to back. Photograph: iStock

Venture capitalist Seroba Life Sciences is eyeing several candidates for investment from the €100 million fund it has just launched. The firm said (...)

Peter Sandys, managing partner at Seroba Life Sciences, and Aidan Meagher, head of life sciences at EY: “It is essential that we continue to nurture high potential start-ups and give them the opportunity to grow their business”

At an event in Dublin this week, more than 50 medtech start-ups will pitch for funding from venture capital firms with more than €13 billion in funds (...)

President Higgins will make an address on the importance of scientific and technological co-operation between Ireland and Britain during his State visit this week. photograph: gareth chaney/collins

More than 120 business leaders are expected to attend Ireland Day at the London Stock Exchange this week, which will coincide with the historic(...)

Peter Sandys, managing partner of Seroba Kernel, said regulatory developments in the US are helping to boost the Republic’s already prominent position in the global medical technology industry.

Investors with more than €6 billion in funds are eyeing opportunities in the Irish medical technology industry, whose exports are worth €8 billio(...)